JAMA Dermatology
@jamadermatology.com
JAMA Dermatology is a member of the JAMA Network, a consortium of peer-reviewed, general medical and specialty publications.
🌐 JAMADermatology.com
🌐 JAMADermatology.com
In this episode of the JAMA Dermatology Author Interviews podcast, Arash Mostaghimi, MD, MPH, discusses trends in advanced practice clinician involvement and specialty drug spending in dermatology with host Ade Adamson, MD, MPP.
🎧 Listen now:
ja.ma/3LR4Ssa
🎧 Listen now:
ja.ma/3LR4Ssa
January 17, 2026 at 2:00 PM
In this episode of the JAMA Dermatology Author Interviews podcast, Arash Mostaghimi, MD, MPH, discusses trends in advanced practice clinician involvement and specialty drug spending in dermatology with host Ade Adamson, MD, MPP.
🎧 Listen now:
ja.ma/3LR4Ssa
🎧 Listen now:
ja.ma/3LR4Ssa
Between 2013 and 2022, the share of #Dermatology specialty drug spending by advanced practice clinicians rose from 10% to 31%, driven by a faster increase in APC numbers and prescribing intensity compared to physicians. ja.ma/3NmRblg
January 16, 2026 at 3:00 PM
Between 2013 and 2022, the share of #Dermatology specialty drug spending by advanced practice clinicians rose from 10% to 31%, driven by a faster increase in APC numbers and prescribing intensity compared to physicians. ja.ma/3NmRblg
Activating #EGFR variants were identified in early-onset, severe generalized #AcanthosisNigricans with pulmonary nodules; EGFR inhibitor therapy improved both skin and lung disease. ja.ma/4bw0Rnp
January 15, 2026 at 3:00 PM
Activating #EGFR variants were identified in early-onset, severe generalized #AcanthosisNigricans with pulmonary nodules; EGFR inhibitor therapy improved both skin and lung disease. ja.ma/4bw0Rnp
Once-daily oral ICP-332, a tyrosine kinase 2 inhibitor, showed favorable safety and significantly improved disease severity versus placebo in adults with moderate to severe #AtopicDermatitis.
ja.ma/4qRwGeK
ja.ma/4qRwGeK
January 14, 2026 at 8:36 PM
Once-daily oral ICP-332, a tyrosine kinase 2 inhibitor, showed favorable safety and significantly improved disease severity versus placebo in adults with moderate to severe #AtopicDermatitis.
ja.ma/4qRwGeK
ja.ma/4qRwGeK
Eosinophilic fasciitis (EF) is a rare disease in which the fascia, the tissue that covers the muscles, becomes inflamed.
📄 This Patient Page describes the symptoms, diagnosis, and treatment of eosinophilic fasciitis.
ja.ma/456KTwd
📄 This Patient Page describes the symptoms, diagnosis, and treatment of eosinophilic fasciitis.
ja.ma/456KTwd
January 10, 2026 at 3:00 PM
Eosinophilic fasciitis (EF) is a rare disease in which the fascia, the tissue that covers the muscles, becomes inflamed.
📄 This Patient Page describes the symptoms, diagnosis, and treatment of eosinophilic fasciitis.
ja.ma/456KTwd
📄 This Patient Page describes the symptoms, diagnosis, and treatment of eosinophilic fasciitis.
ja.ma/456KTwd
Case report describes a patient in his 50s with immunoglobulin A vasculitis with monoclonal B-cell lymphocytosis who was successfully treated with zanubrutinib after failure of multiple treatments. ja.ma/49HVRuF
January 9, 2026 at 3:00 PM
Case report describes a patient in his 50s with immunoglobulin A vasculitis with monoclonal B-cell lymphocytosis who was successfully treated with zanubrutinib after failure of multiple treatments. ja.ma/49HVRuF
An adolescent female presented with 3 days of progressive abdominal pain and reported that a rash first appeared nearly 1 year earlier on her left wrist and gradually spread over several weeks.
What is your diagnosis? ja.ma/4qItEcH
What is your diagnosis? ja.ma/4qItEcH
January 8, 2026 at 3:00 PM
An adolescent female presented with 3 days of progressive abdominal pain and reported that a rash first appeared nearly 1 year earlier on her left wrist and gradually spread over several weeks.
What is your diagnosis? ja.ma/4qItEcH
What is your diagnosis? ja.ma/4qItEcH
Transcutaneous auricular vagus nerve stimulation improved facial erythema, flushing, and related systemic symptoms among patients with patients with erythematotelangiectatic #rosacea compared to sham treatment.
ja.ma/3Z01e20
ja.ma/3Z01e20
January 8, 2026 at 1:00 PM
Transcutaneous auricular vagus nerve stimulation improved facial erythema, flushing, and related systemic symptoms among patients with patients with erythematotelangiectatic #rosacea compared to sham treatment.
ja.ma/3Z01e20
ja.ma/3Z01e20
Systematic review: Accurate classification of dermatologic conditions using International Classification of Diseases (ICD) codes is essential for research that uses large administrative datasets. ja.ma/4qANZRk
January 7, 2026 at 5:00 PM
Systematic review: Accurate classification of dermatologic conditions using International Classification of Diseases (ICD) codes is essential for research that uses large administrative datasets. ja.ma/4qANZRk
Among bionaive patients with #Psoriasis in Denmark, ustekinumab had superior drug survival compared with adalimumab and secukinumab over 5 years. ja.ma/45kP3AP
January 7, 2026 at 4:30 PM
Among bionaive patients with #Psoriasis in Denmark, ustekinumab had superior drug survival compared with adalimumab and secukinumab over 5 years. ja.ma/45kP3AP
A woman in her 70s presented with a 5-year history of pruritic, thickened plaques involving the trunk and extremities. Despite intermittent treatment with antihistamines and glucocorticoids, the condition progressed.
Read the full case report: ja.ma/49kbXJD
Read the full case report: ja.ma/49kbXJD
January 7, 2026 at 2:00 PM
A woman in her 70s presented with a 5-year history of pruritic, thickened plaques involving the trunk and extremities. Despite intermittent treatment with antihistamines and glucocorticoids, the condition progressed.
Read the full case report: ja.ma/49kbXJD
Read the full case report: ja.ma/49kbXJD
Psoriasis patients treated with ustekinumab had a lower five-year risk of developing cancer (excluding nonmelanoma skin cancer) compared to those on adalimumab, while risk for secukinumab was similar but limited by small sample size. ja.ma/49ooiMZ
January 7, 2026 at 12:00 PM
Psoriasis patients treated with ustekinumab had a lower five-year risk of developing cancer (excluding nonmelanoma skin cancer) compared to those on adalimumab, while risk for secukinumab was similar but limited by small sample size. ja.ma/49ooiMZ
Acne keloidalis nuchae (AKN) is a chronic skin condition characterized by inflamed hair follicles that can cause hair loss and substantial scarring.
This Patient Page describes the symptoms, diagnosis, and treatment of AKN. ja.ma/4bfbuuD
This Patient Page describes the symptoms, diagnosis, and treatment of AKN. ja.ma/4bfbuuD
January 4, 2026 at 1:00 PM
Acne keloidalis nuchae (AKN) is a chronic skin condition characterized by inflamed hair follicles that can cause hair loss and substantial scarring.
This Patient Page describes the symptoms, diagnosis, and treatment of AKN. ja.ma/4bfbuuD
This Patient Page describes the symptoms, diagnosis, and treatment of AKN. ja.ma/4bfbuuD
Lamellar ichthyosis (LI) is a rare autosomal recessive disorder characterized by widespread, thick, platelike scales.
This case report describes 2 siblings in their 20s with lamellar ichthyosis treated with acitretin and dupilumab. ja.ma/45mH99S
This case report describes 2 siblings in their 20s with lamellar ichthyosis treated with acitretin and dupilumab. ja.ma/45mH99S
January 3, 2026 at 1:00 PM
Lamellar ichthyosis (LI) is a rare autosomal recessive disorder characterized by widespread, thick, platelike scales.
This case report describes 2 siblings in their 20s with lamellar ichthyosis treated with acitretin and dupilumab. ja.ma/45mH99S
This case report describes 2 siblings in their 20s with lamellar ichthyosis treated with acitretin and dupilumab. ja.ma/45mH99S
The EBSdart scoring tool reliably measures disease severity in epidermolysis bullosa simplex across age groups, showing strong interrater agreement and generalizability, and may aid future clinical trials and therapy development.
ja.ma/49j9KhF
ja.ma/49j9KhF
January 2, 2026 at 2:00 PM
The EBSdart scoring tool reliably measures disease severity in epidermolysis bullosa simplex across age groups, showing strong interrater agreement and generalizability, and may aid future clinical trials and therapy development.
ja.ma/49j9KhF
ja.ma/49j9KhF
Botulinum toxin injections were associated with high complete response rates for acute digital ischemia (93.1%), ischemic ulcers (90.1%), and gangrene (87.5%), with minimal adverse events.
ja.ma/4phELs4
ja.ma/4phELs4
January 1, 2026 at 2:00 PM
Botulinum toxin injections were associated with high complete response rates for acute digital ischemia (93.1%), ischemic ulcers (90.1%), and gangrene (87.5%), with minimal adverse events.
ja.ma/4phELs4
ja.ma/4phELs4
The EBSdart scoring tool reliably measures disease severity in epidermolysis bullosa simplex across age groups, showing strong interrater agreement and generalizability, and may aid future clinical trials and therapy development. ja.ma/44OsEvg
December 31, 2025 at 1:00 PM
The EBSdart scoring tool reliably measures disease severity in epidermolysis bullosa simplex across age groups, showing strong interrater agreement and generalizability, and may aid future clinical trials and therapy development. ja.ma/44OsEvg
Viewpoint: #Melanoma in situ is a main contributor to melanoma overdiagnosis, and reframing it as a precancer could help mitigate emotional and physical harms for patients. ja.ma/3YbCjIG
December 30, 2025 at 1:00 PM
Viewpoint: #Melanoma in situ is a main contributor to melanoma overdiagnosis, and reframing it as a precancer could help mitigate emotional and physical harms for patients. ja.ma/3YbCjIG
In a case series of patients with severe alopecia areata, some who failed treatment with one or more Janus kinase inhibitors (JAKis) responded to a different JAKi, suggesting that switching JAKis may benefit nonresponders and support personalized therapy. ja.ma/4q0n6Xd
December 28, 2025 at 3:00 PM
In a case series of patients with severe alopecia areata, some who failed treatment with one or more Janus kinase inhibitors (JAKis) responded to a different JAKi, suggesting that switching JAKis may benefit nonresponders and support personalized therapy. ja.ma/4q0n6Xd
The ICD-10 code L80 was found to have high accuracy for identifying vitiligo, with the highest positive predictive value when codes are combined with treatment data. ja.ma/4q10ENy
December 27, 2025 at 1:00 PM
The ICD-10 code L80 was found to have high accuracy for identifying vitiligo, with the highest positive predictive value when codes are combined with treatment data. ja.ma/4q10ENy
This case report describes a man in his 30s who presented for evaluation of a 3-week history of irritation, redness, and photophobia in both eyes.
ja.ma/3KOUwsx
ja.ma/3KOUwsx
December 25, 2025 at 1:00 PM
This case report describes a man in his 30s who presented for evaluation of a 3-week history of irritation, redness, and photophobia in both eyes.
ja.ma/3KOUwsx
ja.ma/3KOUwsx
The numbers are in.
This year's most popular JAMA Network content spans a range of topics, from #fluoride to #Parkinson disease to #GLP-1s. What was your favorite article in 2025, and did other readers agree?
🔗 ja.ma/49dC70E
This year's most popular JAMA Network content spans a range of topics, from #fluoride to #Parkinson disease to #GLP-1s. What was your favorite article in 2025, and did other readers agree?
🔗 ja.ma/49dC70E
December 25, 2025 at 12:00 PM
The numbers are in.
This year's most popular JAMA Network content spans a range of topics, from #fluoride to #Parkinson disease to #GLP-1s. What was your favorite article in 2025, and did other readers agree?
🔗 ja.ma/49dC70E
This year's most popular JAMA Network content spans a range of topics, from #fluoride to #Parkinson disease to #GLP-1s. What was your favorite article in 2025, and did other readers agree?
🔗 ja.ma/49dC70E
Patient-Reported Outcomes Measurement Information System (PROMIS) measures for pain, itch, social satisfaction, and isolation showed strong validity and tracked clinical improvements in adults with chronic skin disease. ja.ma/3LcjT7H
December 24, 2025 at 3:00 PM
Patient-Reported Outcomes Measurement Information System (PROMIS) measures for pain, itch, social satisfaction, and isolation showed strong validity and tracked clinical improvements in adults with chronic skin disease. ja.ma/3LcjT7H
Latine patients with #HidradenitisSuppurativa report unmet wound care and pain management needs, frequent self-directed care, and barriers created by interpreter-mediated communication, supporting the need for improved multidisciplinary approaches. ja.ma/4b1j0cu
December 23, 2025 at 5:00 PM
Latine patients with #HidradenitisSuppurativa report unmet wound care and pain management needs, frequent self-directed care, and barriers created by interpreter-mediated communication, supporting the need for improved multidisciplinary approaches. ja.ma/4b1j0cu
The numbers are in.
The numbers are in. This year's most popular JAMA Network content spans a range of topics, from #fluoride to #Parkinson disease to #GLP-1s. What was your favorite article in 2025 -- and did other readers agree?
🔗 ja.ma/3KI8NY0
The numbers are in. This year's most popular JAMA Network content spans a range of topics, from #fluoride to #Parkinson disease to #GLP-1s. What was your favorite article in 2025 -- and did other readers agree?
🔗 ja.ma/3KI8NY0
December 23, 2025 at 4:30 PM
The numbers are in.
The numbers are in. This year's most popular JAMA Network content spans a range of topics, from #fluoride to #Parkinson disease to #GLP-1s. What was your favorite article in 2025 -- and did other readers agree?
🔗 ja.ma/3KI8NY0
The numbers are in. This year's most popular JAMA Network content spans a range of topics, from #fluoride to #Parkinson disease to #GLP-1s. What was your favorite article in 2025 -- and did other readers agree?
🔗 ja.ma/3KI8NY0